Literature DB >> 7702984

The development and progression of adenocarcinoma of the lung.

M Noguchi1, Y Shimosato.   

Abstract

This chapter has briefly reviewed the development and progression of peripheral-type adenocarcinoma of the lung, focusing particularly on bronchioloalveolar carcinoma consisting of the nonmucus-producing cell type with or without sclerosis. Histoloical examination reveals that scar cancers are rare except in cases of diffuse pulmonary fibrosis and that many nonmucus-producing bronchioloalveolar carcinomas appear to develop from atypical adenomatous hyperplasia, which can be called adenoma or very well-differentiated adenocarcinoma, and to progress stepwise. Stepwise progression in malignancy can be disclosed not only by cytological and histological examination but also by proliferative activity of the tumor, such as mitotic activity, the percentage of DNA-synthesizing cells and the frequency of proliferating cell nuclear antigen-positive cells, the mean nuclear DNA content of tumor cells and occurrence of aneuploid cell lines, and abnormalities of oncogenes (c-Ki-ras, myc family, and c-erbB2), such as point mutation, rearrangement, amplification, and tumor suppressor genes (point mutation and deletion) such as p53.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7702984     DOI: 10.1007/978-1-4615-2630-8_6

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN: 0927-3042


  13 in total

1.  Long term follow-up for small pure ground-glass nodules: implications of determining an optimum follow-up period and high-resolution CT findings to predict the growth of nodules.

Authors:  Shotaro Takahashi; Nobuyuki Tanaka; Tomoaki Okimoto; Toshiki Tanaka; Kazuhiro Ueda; Tsuneo Matsumoto; Kazuto Ashizawa; Yoshie Kunihiro; Shoji Kido; Naofumi Matsunaga
Journal:  Jpn J Radiol       Date:  2011-12-22       Impact factor: 2.374

2.  Effect of gravitation for detection of bronchioloalveolar carcinoma on computed tomography.

Authors:  Takahiko Misao; Kanji Minamoto; Hideharu Nakano; Masataka Yamane; Yosuke Yamamoto; Katashi Satoh
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2005-06

Review 3.  The pulmonary nodule: clinical and radiological characteristics affecting a diagnosis of malignancy.

Authors:  L Cardinale; F Ardissone; S Novello; M Busso; F Solitro; M Longo; D Sardo; M Giors; C Fava
Journal:  Radiol Med       Date:  2009-05-29       Impact factor: 3.469

Review 4.  Decision making in patients with pulmonary nodules.

Authors:  David E Ost; Michael K Gould
Journal:  Am J Respir Crit Care Med       Date:  2011-10-06       Impact factor: 21.405

Review 5.  Controversies on lung cancers manifesting as part-solid nodules.

Authors:  Rowena Yip; Kunwei Li; Li Liu; Dongming Xu; Kathleen Tam; David F Yankelevitz; Emanuela Taioli; Betsy Becker; Claudia I Henschke
Journal:  Eur Radiol       Date:  2017-08-23       Impact factor: 5.315

Review 6.  Management of CT screen-detected lung nodule: the thoracic surgeon perspective.

Authors:  Adnan M Al-Ayoubi; Raja M Flores
Journal:  Ann Transl Med       Date:  2016-04

7.  One-dimensional mean computed tomography value evaluation of ground-glass opacity on high-resolution images.

Authors:  Akihiko Kitami; Yoshito Kamio; Shoko Hayashi; Kosuke Suzuki; Shugo Uematsu; Ryozo Gen; Takashi Suzuki; Mitsutaka Kadokura
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-06-01

8.  The association between atypical adenomatous hyperplasia and primary lung cancer.

Authors:  A D Chapman; K M Kerr
Journal:  Br J Cancer       Date:  2000-09       Impact factor: 7.640

9.  Epigenetic clustering of lung adenocarcinomas based on DNA methylation profiles in adjacent lung tissue: Its correlation with smoking history and chronic obstructive pulmonary disease.

Authors:  Takashi Sato; Eri Arai; Takashi Kohno; Yoriko Takahashi; Sayaka Miyata; Koji Tsuta; Shun-ichi Watanabe; Kenzo Soejima; Tomoko Betsuyaku; Yae Kanai
Journal:  Int J Cancer       Date:  2014-07-15       Impact factor: 7.396

Review 10.  Progression and metastasis of lung cancer.

Authors:  Helmut H Popper
Journal:  Cancer Metastasis Rev       Date:  2016-03       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.